AI-supported mammography screening reduces advanced breast cancer rates and improves early detection, according to the largest randomized controlled trial to date.
Key Details
- 1Over 100,000 Swedish women were randomized to AI-supported vs. standard double-reading mammography screening.
- 2AI-supported screening resulted in a 12% reduction in interval (between-screening) breast cancer diagnoses.
- 316% fewer invasive, 21% fewer large, and 27% fewer aggressive subtype cancers were identified in the AI arm.
- 481% of cancers were detected at screening with AI, versus 74% in the control group—a 9% increase.
- 5False positive rates were similar between groups (1.5% AI, 1.4% control), and radiologist workload was reduced by 44% in interim analyses.
- 6The study supports use of tested AI tools as an aid—not a replacement—for radiologists, especially amid workforce shortages.
Why It Matters
This landmark trial shows substantial clinical benefit and workflow relief from using AI in breast cancer screening, supporting adoption in radiology programs facing growing patient volumes and staff shortages. The findings may shape future screening guidelines and training requirements for imaging AI use.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.